Double dose of Tamiflu proves no better in severe flu
LONDON (Reuters) - There are no benefits from giving patients with severe flu a double dose of Roche's drug Tamiflu, despite calls b...
Read More »LONDON (Reuters) - There are no benefits from giving patients with severe flu a double dose of Roche's drug Tamiflu, despite calls b...
Read More »(Reuters) - The Food and Drug Administration has for the third time refused approval to Endo Health Solutions Inc's injectable testo...
Read More »By Kerry Grens NEW YORK (Reuters Health) - Tranquilizers known as benzodiazepines and certain older antidepressants are linked with ...
Read More »LONDON (Reuters) - Five top Japanese drug companies are to open their "libraries" of experimental compounds to scrutiny by scientist...
Read More »By Kathryn Doyle NEW YORK (Reuters Health) - They are a fad that refuses to fade, but no solid evidence exists to show whether or no...
Read More »By Genevra Pittman NEW YORK (Reuters Health) - Losing weight may ease psoriasis and improve quality of life for some overweight peop...
Read More »
By Ben Hirschler LONDON (Reuters) - GlaxoSmithKline is betting on a new vaccine technology based on chimpanzee viruses by acquiring ...
Read More »
PARIS (Reuters) - France's health regulator said on Thursday it would comply with the European Commission if it ruled that Bayer acn...
Read More »By Padraic Halpin DUBLIN (Reuters) - Irish drugmaker Elan will lay out an alternative strategy if shareholders reject a string of pl...
Read More »
By P.J. Huffstutter and Lisa Baertlein CHICAGO/LOS ANGELES (Reuters) - When Smithfield Foods Inc. quietly weaned the first of its pi...
Read More »